← Back to Clinical Trials
Recruiting NCT07038681

NCT07038681 Mediterranean Diet Intervention for Maternal Postpartum

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07038681
Status Recruiting
Phase
Sponsor Universidade do Porto
Condition Postpartum
Study Type INTERVENTIONAL
Enrollment 52 participants
Start Date 2025-05-31
Primary Completion 2025-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Mediterranean Diet Intervention GroupControl Group (Standard Hospital Dietary Care)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 52 participants in total. It began in 2025-05-31 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The increasing prevalence of obesity during women's reproductive years highlights the need for effective strategies to improve nutritional literacy as a preventive approach to adverse postnatal outcomes. This study outlines a protocol for a pilot randomized controlled trial assessing the potential of nutritional education sessions promoting the Mediterranean Diet (MedDiet) to improve adherence to this diet and evaluate its effects on cardiometabolic outcomes, namely on cardiac reverse remodeling, glycemic and blood pressure control, as well as on preconception weight recovery and changes in the fecal microbiota composition in pregnant women with obesity, hypertension, and/or diabetes. Secondarily, this study aims to evaluate how this dietary intervention indirectly interferes with infants' exclusive breastfeeding and the introduction of complementary feeding. It includes a face-to-face session using an eye-catching 13-page manual, followed by five monthly newsletters sent by e-mail. Participants will be monitored at one, six, and twelve months postpartum to evaluate the intervention's effectiveness. Findings from this study will contribute to the development of an evidence-based nutritional education tool designed to improve maternal health outcomes, with potential applicability for both health professionals and pregnant and postpartum women.

Eligibility Criteria

Inclusion Criteria: * Adult female (\>18 years old) * Obesity * Chronic arterial hypertension * Type 2 diabetes * Gestational hypertension * Gestational diabetes Exclusion Criteria: * Preexisting cardiomyopathy; * Renal disease; * Chronic obstructive airway disease; * Active systemic infection; * Genetic syndromes; * Type 1 Diabetes mellitus

Contact & Investigator

Central Contact

Juliana Morais, Master

✉ ju_morais17@hotmail.com

📞 220426820

Principal Investigator

Inês Falcão Pires, PhD

PRINCIPAL INVESTIGATOR

Universidade do Porto

Frequently Asked Questions

Who can join the NCT07038681 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Postpartum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07038681 currently recruiting?

Yes, NCT07038681 is actively recruiting participants. Contact the research team at ju_morais17@hotmail.com for enrollment information.

Where is the NCT07038681 trial being conducted?

This trial is being conducted at Porto, Portugal.

Who is sponsoring the NCT07038681 clinical trial?

NCT07038681 is sponsored by Universidade do Porto. The principal investigator is Inês Falcão Pires, PhD at Universidade do Porto. The trial plans to enroll 52 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology